Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06094413 · ClinicalTrials.gov registry record · NA

Effects of Multicomponent Training in Older Adults

A NA study of Sarcopenia, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06094413 is a NA study of Sarcopenia that has completed, run by Geisinger Clinic. The registered enrollment target is 20 participants, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06094413, a NA study of Sarcopenia, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study was to determine whether community-dwelling older adults would experience improved patient-reported outcomes and physical performance after completing an 8-week multicomponent exercise training program when compared to a control group who did not complete the intervention. As an additional aim, subjects who participated in the exercise intervention were asked about their experiences to identify factors that contributed to positive health behaviors in community-dwelling older adults.

Conditions Studied

Interventions

  • BEHAVIORAL Multicomponent Training Intervention

Study Locations (1)

Pennsylvania

  • Geisinger 65Forward - Scranton

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-03-04
Est. Completion 2024-12-17
Phase NA

Sponsor

Geisinger Clinic

107 total trials

What the Registry Record Tells You About NCT06094413

The ClinicalTrials.gov registry entry for NCT06094413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (75% lower). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 1 intervention - of which Multicomponent Training Intervention is the first listed.

NCT06094413 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06094413 about?

NCT06094413 is a clinical study titled "Effects of Multicomponent Training in Older Adults". The purpose of the study was to determine whether community-dwelling older adults would experience improved patient-reported outcomes and physical performance after completing an 8-week multicomponent exercise training program when compared to a control group who did not complete the intervention. A...

What is the current status of trial NCT06094413?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-04. Estimated completion is 2024-12-17.

What conditions does trial NCT06094413 study?

This clinical trial studies the following conditions: Sarcopenia.

What interventions are being tested in trial NCT06094413?

The interventions under investigation include: Multicomponent Training Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06094413?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06094413 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.